Metagenomic Next-Generation Sequencing in Infectious Diseases: Clinical Applications, Translational Challenges, and Future Directions
Top Cited Papers
Open Access
- 8 August 2025
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 15 (16) , 1991
Abstract
Metagenomic next-generation sequencing (mNGS) is transforming infectious disease diagnostics by enabling simultaneous, hypothesis-free detection of a broad array of pathogens—including bacteria, viruses, fungi, and parasites—directly from clinical specimens such as cerebrospinal fluid, blood, and bronchoalveolar lavage fluid. Unlike traditional culture and targeted molecular assays, mNGS serves as a powerful complementary approach, capable of identifying novel, fastidious, and polymicrobial infections while also characterizing antimicrobial resistance (AMR) genes. These advantages are particularly relevant in diagnostically challenging scenarios, such as infections in immunocompromised patients, sepsis, and culture-negative cases. Despite its potential, mNGS remains underutilized in clinical microbiology due to persistent gaps between its technical capabilities and routine diagnostic adoption. This review addresses key translational challenges that limit the broader implementation of mNGS, especially in resource-constrained and critical care settings. We provide a comprehensive overview of the entire workflow—from sample processing and host DNA depletion to sequencing platforms and downstream bioinformatics—and highlight sources of variability, including contamination, human DNA interference, and inconsistencies in resistance gene annotation. Additionally, we explore the ethical, legal, and privacy implications of host genomic data, as well as economic and regulatory obstacles hindering mNGS integration into standard clinical practice. To illustrate clinical relevance, we examine real-world evidence from large-scale trials such as MATESHIP, GRAIDS, DISQVER, and NGS-CAP. Finally, we outline future directions involving artificial intelligence, multi-omics integration, cloud-based analytics, and portable sequencing technologies for point-of-care diagnostics. By addressing both current limitations and emerging innovations, this review offers a translational framework for integrating mNGS into precision diagnostics and infection management across diverse healthcare environments.Keywords
This publication has 121 references indexed in Scilit:
- Clinical impact of bronchoalveolar lavage fluid metagenomic next-generation sequencing in immunocompromised patients with severe community-acquired pneumonia in ICU: a multicenter retrospective studyInfection, 2025
- Claim Denials for Cancer-Related Next-Generation Sequencing in MedicareJAMA Network Open, 2025
- The application status of sequencing technology in global respiratory infectious disease diagnosisInfection, 2024
- Effect of Metagenomic Next-Generation Sequencing on Clinical Outcomes of Patients With Severe Community-Acquired Pneumonia in the ICUChest, 2024
- Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host PneumoniaPharmacoEconomics, 2024
- Pathogen detection in suspected spinal infection: metagenomic next-generation sequencing versus cultureEuropean Spine Journal, 2023
- Diagnosis of infectious diseases in immunocompromised hosts using metagenomic next generation sequencing-based diagnosticsBlood Reviews, 2022
- Next-Generation Sequencing (NGS)2021
- Bacterial genome sequencing in clinical microbiology: a pathogen-oriented reviewEuropean Journal of Clinical Microbiology & Infectious Diseases, 2017
- Diagnostic Test Accuracy of a 2-Transcript Host RNA Signature for Discriminating Bacterial vs Viral Infection in Febrile ChildrenJAMA, 2016